Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 6, 2004, Pages 463-467

  Malyszko, Jolanta ^a   Malyszko, Jacek S ^a   Hryszko, Tomasz ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Chronic ambulatory peritoneal dialysis; Endothelium; Hemostasis; Lipids; Platelets; sCD40L; Simvastatin

Indexed keywords

CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; SIMVASTATIN; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; LONG TERM CARE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION;

ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CD40 LIGAND; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; P-SELECTIN; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PLATELET AGGREGATION; SIMVASTATIN; SOLUBILITY; VON WILLEBRAND FACTOR;

EID: 4444273474     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200408000-00004     Document Type: Article

References (28)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997; 96:396-399.
3. Urbich C, Mallat Z, Tedgiu A, Clauss M, Zeiher AM, Dimmeler S. Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial cells. J Clin Invest 2001; 108:1451-1458.
4. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA. CD40 ligand on activated platelet triggers an inflammatory reaction of endothelial cells. Nature 1998; 391:591-594.
5. Slupsky JR, Kalbas M, Willuweit A, Henn V, Kroczek RA, Muller-Berghaus G. Activated platelet induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998; 80:1008-1014.
6. Lindner A, Charra B, Sherrad DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974; 290:697-701.
7. Bloembergen WE, Prot FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:184-191.
8. Kawaguchi Y, Kubo H, Yamamoto H, Nakayama K, Shigematsu T, Sakai O. Is atherosclerosis accelerated by CAPD? Perit Dial Int 1996; 16(suppl 1):S23-S30.
9. Blumenthal RS. Statins: effective antiatherosclerotic therapy. Am Heart J 2000; 139:577-583.
10. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1999; 279:1643-1650.
11. Małyszko J, Małyszko JS, Hryszko T, Myṡliwiec M. Effects of long-term treatment with simvastatin on some hemostatic parameters in CAPD patients. Am J Nephrol 2001, 21:373-378.
12. Semb AG, van Wissen S, Ueland T, Smilde T, Waehre T, Tripp MD, et al. Raised serum levels of soluble CD 40 L in patients with familial hypercholesterolemia: downregulatory effects of statin therapy. J Am Coll Cardiol 2003; 41:275-279.
13. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML, for the CAPTURE Study Investigators. Soluble CD 40 ligand in acute coronary syndromes. N Engl J Med 2003; 348:1104-1111.
14. Blake GJ, Ostfeld RJ, Yucel EK, Varo N, Schonbeck U, Blake MA, et al. Soluble CD 40 ligand levels indicate lipid accumulation in carotid atheroma. Arterioscler Thromb Vasc Biol 2003; 23:e11-e14.
15. Locatelli F, Del Vecchio L, Manzoni C. Morbidity and mortality on maintenance hemodialysis. Nephron 1998; 80:380-400.
16. Malyszko J, Urano T, Knofler R, Taminato A, Yoshimi T, Takada Y, Takada A. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thromb Res 1994; 75:569-576.
17. Malyszko J, Malyszko JS, Mysliwiec M, Takada Y, Takada A. Cyclosporine and FK 506 affect platelet function in vitro. Platelets 1995; 6:366-370.
18. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927-929.
19. Schwabe RF, Engelman H, Hess S, Fricke H. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients. Clin Exp Immunol 1999; 117:153-158.
20. Aukrust P, Muller F, Ueland T, Berget T, Aaser E, Brunsvig A, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Circulation 1999; 100:614-620.
21. Cipollone F, Mezzetti A, Porreca E, Di Febbo C, Nutini M, Fazia M, et al. Association between enhanced soluble CD 40L and prothrombotic state in hypercholesterolemia. Effects of statin therapy. Circulation 2002; 106:399-402.
22. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM. Soluble CD 40 L and cardiovascular risk in women. Circulation 2001; 104:2266-2268.
23. Garlichs CD, John S, Schmiesser A, Eskafi S, Stumpf C, Karl M, et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 2001; 104:2395-2400.
24. Malyszko J, Malyszko JS, Mysliwiec M. Comparison of hemostatic disturbances between patients on CAPD and HD. Perit Dial Int 2001; 21:158-165.
25. LaRosa JC. Effects of statins on risk of coronary disease. A meta-analysis of randomized trials. JAMA 1999; 282:2340-2346.
26. Farmer JA. Pleiotropic effects of statins. Curr Atheroscler Rev 2000; 2:208-217.
27. Altierei DC. Statins begins to sprout. J Clin Invest 2001; 108:365-366.
28. Schonbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD 40 and CD 40L expression in human vascular cells. Circulation 2002; 106:2888-2893.